Alexander Horswill
Concepts (659)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 121 | 2026 | 455 | 26.500 |
Why?
| | Staphylococcal Infections | 97 | 2025 | 388 | 22.240 |
Why?
| | Bacterial Proteins | 93 | 2026 | 955 | 11.760 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 45 | 2026 | 248 | 11.670 |
Why?
| | Biofilms | 56 | 2025 | 278 | 10.840 |
Why?
| | Quorum Sensing | 38 | 2026 | 79 | 8.660 |
Why?
| | Skin | 24 | 2026 | 755 | 6.050 |
Why?
| | Gene Expression Regulation, Bacterial | 41 | 2026 | 327 | 5.490 |
Why?
| | Staphylococcus epidermidis | 24 | 2024 | 77 | 5.280 |
Why?
| | Staphylococcal Skin Infections | 12 | 2026 | 41 | 4.810 |
Why?
| | Virulence Factors | 27 | 2026 | 172 | 4.370 |
Why?
| | Staphylococcus | 11 | 2022 | 74 | 3.350 |
Why?
| | Virulence | 30 | 2026 | 278 | 3.300 |
Why?
| | Trans-Activators | 20 | 2026 | 405 | 3.070 |
Why?
| | Anti-Bacterial Agents | 35 | 2025 | 1907 | 3.050 |
Why?
| | Peptides, Cyclic | 19 | 2019 | 275 | 2.880 |
Why?
| | Bacterial Adhesion | 14 | 2025 | 109 | 2.850 |
Why?
| | Adhesins, Bacterial | 10 | 2026 | 46 | 2.500 |
Why?
| | Peptides | 17 | 2024 | 995 | 2.080 |
Why?
| | Neutrophils | 23 | 2026 | 1134 | 1.970 |
Why?
| | Host-Pathogen Interactions | 14 | 2024 | 371 | 1.740 |
Why?
| | Protein Kinases | 9 | 2026 | 315 | 1.690 |
Why?
| | Mice | 65 | 2026 | 18339 | 1.620 |
Why?
| | Phagocytosis | 12 | 2026 | 299 | 1.590 |
Why?
| | Animals | 92 | 2026 | 38058 | 1.550 |
Why?
| | Micrococcal Nuclease | 7 | 2024 | 26 | 1.510 |
Why?
| | Dermatitis, Atopic | 4 | 2024 | 321 | 1.470 |
Why?
| | Hemolysin Proteins | 9 | 2018 | 36 | 1.460 |
Why?
| | Keratinocytes | 8 | 2025 | 248 | 1.370 |
Why?
| | Lipoproteins | 5 | 2024 | 169 | 1.350 |
Why?
| | Membrane Proteins | 8 | 2024 | 1166 | 1.310 |
Why?
| | Bacterial Toxins | 13 | 2023 | 109 | 1.240 |
Why?
| | Peptide Hydrolases | 11 | 2024 | 105 | 1.240 |
Why?
| | Mutagenesis | 3 | 2025 | 192 | 1.180 |
Why?
| | Immune Evasion | 8 | 2026 | 64 | 1.130 |
Why?
| | Staphylococcus hominis | 2 | 2025 | 3 | 1.130 |
Why?
| | Coinfection | 4 | 2023 | 141 | 1.130 |
Why?
| | Streptococcus pyogenes | 3 | 2026 | 41 | 1.120 |
Why?
| | Microbial Sensitivity Tests | 15 | 2025 | 370 | 1.100 |
Why?
| | Humans | 113 | 2026 | 144759 | 1.010 |
Why?
| | Pruritus | 2 | 2024 | 59 | 1.010 |
Why?
| | Prosthesis-Related Infections | 3 | 2025 | 99 | 0.980 |
Why?
| | Fibrinogen | 6 | 2023 | 177 | 0.960 |
Why?
| | Vagina | 3 | 2025 | 201 | 0.960 |
Why?
| | Bacteriocins | 1 | 2025 | 4 | 0.950 |
Why?
| | Microbial Interactions | 2 | 2019 | 19 | 0.950 |
Why?
| | Small Molecule Libraries | 2 | 2019 | 111 | 0.940 |
Why?
| | DNA, Bacterial | 7 | 2024 | 342 | 0.930 |
Why?
| | Culture Media | 4 | 2024 | 161 | 0.930 |
Why?
| | Urease | 1 | 2025 | 13 | 0.920 |
Why?
| | Polysaccharide-Lyases | 2 | 2016 | 11 | 0.920 |
Why?
| | Propionates | 8 | 2020 | 39 | 0.900 |
Why?
| | Repressor Proteins | 4 | 2015 | 437 | 0.860 |
Why?
| | Genome, Bacterial | 1 | 2025 | 155 | 0.810 |
Why?
| | Extracellular Space | 4 | 2014 | 120 | 0.800 |
Why?
| | Collagen | 1 | 2026 | 456 | 0.780 |
Why?
| | Wound Infection | 4 | 2026 | 56 | 0.770 |
Why?
| | Endodeoxyribonucleases | 1 | 2023 | 78 | 0.740 |
Why?
| | Mutation | 27 | 2026 | 4089 | 0.730 |
Why?
| | Homeostasis | 2 | 2025 | 640 | 0.710 |
Why?
| | Cysteine Endopeptidases | 3 | 2025 | 73 | 0.710 |
Why?
| | Cathepsin G | 1 | 2021 | 4 | 0.690 |
Why?
| | Bacteremia | 4 | 2020 | 221 | 0.690 |
Why?
| | Metalloproteases | 2 | 2020 | 42 | 0.690 |
Why?
| | Microbiota | 7 | 2025 | 781 | 0.690 |
Why?
| | Agglutination Tests | 1 | 2021 | 4 | 0.670 |
Why?
| | Cell Membrane | 7 | 2021 | 706 | 0.670 |
Why?
| | Symbiosis | 2 | 2020 | 81 | 0.660 |
Why?
| | Microbial Viability | 3 | 2018 | 90 | 0.650 |
Why?
| | Metalloendopeptidases | 5 | 2017 | 62 | 0.650 |
Why?
| | Mice, Inbred C57BL | 20 | 2026 | 5992 | 0.640 |
Why?
| | Streptococcal Infections | 5 | 2026 | 168 | 0.630 |
Why?
| | Chromatography, High Pressure Liquid | 5 | 2020 | 594 | 0.630 |
Why?
| | Disease Models, Animal | 21 | 2026 | 4557 | 0.610 |
Why?
| | Mass Spectrometry | 8 | 2019 | 750 | 0.610 |
Why?
| | Teichoic Acids | 4 | 2026 | 18 | 0.600 |
Why?
| | Immunity, Innate | 9 | 2026 | 846 | 0.600 |
Why?
| | Rabbits | 10 | 2019 | 648 | 0.590 |
Why?
| | Plant Extracts | 4 | 2020 | 187 | 0.590 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2019 | 81 | 0.580 |
Why?
| | Membrane Transport Proteins | 1 | 2020 | 154 | 0.580 |
Why?
| | Protein Binding | 11 | 2026 | 2273 | 0.570 |
Why?
| | Streptococcus agalactiae | 4 | 2026 | 108 | 0.570 |
Why?
| | Salmonella enterica | 6 | 2003 | 59 | 0.560 |
Why?
| | Dehydration | 1 | 2018 | 56 | 0.550 |
Why?
| | Antibiosis | 1 | 2017 | 10 | 0.540 |
Why?
| | Yersinia pestis | 3 | 2013 | 45 | 0.540 |
Why?
| | Disease Transmission, Infectious | 1 | 2018 | 69 | 0.540 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2025 | 561 | 0.520 |
Why?
| | Carrier Proteins | 4 | 2022 | 737 | 0.520 |
Why?
| | Salmonella typhimurium | 7 | 2004 | 190 | 0.510 |
Why?
| | Coenzyme A Ligases | 4 | 2003 | 15 | 0.510 |
Why?
| | Staphylococcus lugdunensis | 1 | 2016 | 2 | 0.500 |
Why?
| | Pseudomonas aeruginosa | 7 | 2023 | 356 | 0.490 |
Why?
| | Catheter-Related Infections | 8 | 2022 | 94 | 0.490 |
Why?
| | Operating Rooms | 1 | 2018 | 146 | 0.490 |
Why?
| | Fagaceae | 1 | 2015 | 2 | 0.470 |
Why?
| | Oleanolic Acid | 1 | 2015 | 9 | 0.460 |
Why?
| | Genes, Bacterial | 8 | 2014 | 166 | 0.460 |
Why?
| | Homoserine | 2 | 2013 | 6 | 0.460 |
Why?
| | Bacteriological Techniques | 2 | 2014 | 68 | 0.460 |
Why?
| | Mice, Inbred BALB C | 7 | 2022 | 1253 | 0.440 |
Why?
| | Lactones | 2 | 2013 | 58 | 0.440 |
Why?
| | Models, Molecular | 11 | 2021 | 1618 | 0.440 |
Why?
| | Gram-Positive Bacteria | 2 | 2017 | 47 | 0.440 |
Why?
| | Transduction, Genetic | 2 | 2014 | 133 | 0.430 |
Why?
| | Macrophages | 6 | 2026 | 1511 | 0.420 |
Why?
| | Environment | 1 | 2016 | 305 | 0.420 |
Why?
| | Endonucleases | 1 | 2014 | 34 | 0.420 |
Why?
| | Hyaluronic Acid | 1 | 2016 | 208 | 0.410 |
Why?
| | Extracellular Matrix | 3 | 2020 | 553 | 0.410 |
Why?
| | Peptide Library | 6 | 2007 | 95 | 0.410 |
Why?
| | beta-Lactams | 2 | 2016 | 32 | 0.390 |
Why?
| | Citrates | 4 | 2004 | 41 | 0.390 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2013 | 16 | 0.390 |
Why?
| | Plasmids | 7 | 2013 | 379 | 0.380 |
Why?
| | Bone Remodeling | 1 | 2013 | 71 | 0.380 |
Why?
| | Bacteriophages | 2 | 2014 | 111 | 0.380 |
Why?
| | Sigma Factor | 2 | 2011 | 43 | 0.380 |
Why?
| | Lectins | 2 | 2024 | 44 | 0.380 |
Why?
| | Bacillus thuringiensis | 1 | 2012 | 6 | 0.380 |
Why?
| | Hydrastis | 1 | 2012 | 3 | 0.380 |
Why?
| | Berberine | 1 | 2012 | 5 | 0.370 |
Why?
| | Superantigens | 4 | 2013 | 70 | 0.370 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 965 | 0.370 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 1499 | 0.370 |
Why?
| | Synovial Fluid | 4 | 2022 | 67 | 0.360 |
Why?
| | Epithelial Cells | 4 | 2024 | 1125 | 0.360 |
Why?
| | Pneumonia, Bacterial | 2 | 2023 | 113 | 0.360 |
Why?
| | Gene Library | 2 | 2010 | 126 | 0.360 |
Why?
| | Fibronectins | 3 | 2022 | 136 | 0.360 |
Why?
| | Coagulase | 3 | 2021 | 6 | 0.350 |
Why?
| | Locomotion | 1 | 2012 | 105 | 0.350 |
Why?
| | Operon | 7 | 2026 | 69 | 0.340 |
Why?
| | Cytotoxins | 3 | 2024 | 16 | 0.340 |
Why?
| | Female | 31 | 2026 | 78271 | 0.340 |
Why?
| | Proteins | 3 | 2006 | 1021 | 0.340 |
Why?
| | Osteomyelitis | 1 | 2013 | 143 | 0.340 |
Why?
| | Genes, Reporter | 3 | 2019 | 275 | 0.340 |
Why?
| | Signal Transduction | 10 | 2024 | 5226 | 0.330 |
Why?
| | Community-Acquired Infections | 2 | 2010 | 174 | 0.330 |
Why?
| | Extracellular Traps | 2 | 2021 | 57 | 0.330 |
Why?
| | Serine Endopeptidases | 3 | 2011 | 128 | 0.330 |
Why?
| | Amoxicillin | 2 | 2024 | 35 | 0.320 |
Why?
| | Plasma | 1 | 2012 | 225 | 0.320 |
Why?
| | Internal Fixators | 1 | 2010 | 32 | 0.300 |
Why?
| | Luminescent Proteins | 3 | 2011 | 185 | 0.300 |
Why?
| | Peptide Biosynthesis | 1 | 2009 | 13 | 0.300 |
Why?
| | Amino Acid Sequence | 11 | 2016 | 2155 | 0.300 |
Why?
| | Anacardiaceae | 2 | 2020 | 4 | 0.290 |
Why?
| | Molecular Sequence Data | 12 | 2014 | 2930 | 0.290 |
Why?
| | Models, Biological | 8 | 2021 | 1821 | 0.290 |
Why?
| | Anti-Infective Agents | 4 | 2023 | 242 | 0.280 |
Why?
| | Polysaccharides | 3 | 2021 | 87 | 0.280 |
Why?
| | Cell Wall | 3 | 2026 | 61 | 0.280 |
Why?
| | Drug Discovery | 3 | 2019 | 155 | 0.280 |
Why?
| | Cells, Cultured | 9 | 2021 | 4154 | 0.270 |
Why?
| | Recombinant Proteins | 7 | 2015 | 1370 | 0.270 |
Why?
| | Inteins | 1 | 2007 | 1 | 0.270 |
Why?
| | DnaB Helicases | 1 | 2007 | 2 | 0.270 |
Why?
| | Synechocystis | 1 | 2007 | 3 | 0.270 |
Why?
| | Sepsis | 3 | 2023 | 640 | 0.260 |
Why?
| | Cysteine Proteases | 2 | 2020 | 8 | 0.260 |
Why?
| | Extracellular Matrix Proteins | 2 | 2024 | 158 | 0.260 |
Why?
| | Hypochlorous Acid | 2 | 2025 | 8 | 0.260 |
Why?
| | Cyclohexanones | 2 | 2017 | 9 | 0.250 |
Why?
| | Promoter Regions, Genetic | 8 | 2018 | 1257 | 0.250 |
Why?
| | Interleukin-1beta | 3 | 2025 | 395 | 0.250 |
Why?
| | Lipopolysaccharides | 2 | 2025 | 863 | 0.250 |
Why?
| | Acyl Coenzyme A | 4 | 2003 | 31 | 0.240 |
Why?
| | Biological Assay | 3 | 2015 | 128 | 0.240 |
Why?
| | Serine Proteases | 1 | 2026 | 26 | 0.240 |
Why?
| | Protein Engineering | 2 | 2004 | 122 | 0.230 |
Why?
| | Base Sequence | 4 | 2023 | 2190 | 0.230 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2014 | 396 | 0.230 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2025 | 198 | 0.230 |
Why?
| | Malassezia | 1 | 2025 | 5 | 0.230 |
Why?
| | Mycobiome | 1 | 2025 | 9 | 0.230 |
Why?
| | Gain of Function Mutation | 1 | 2025 | 36 | 0.230 |
Why?
| | Glycolipids | 1 | 2025 | 52 | 0.220 |
Why?
| | Ammonia | 1 | 2025 | 65 | 0.220 |
Why?
| | Urea | 1 | 2025 | 84 | 0.220 |
Why?
| | Phenols | 2 | 2023 | 114 | 0.220 |
Why?
| | Antimicrobial Cationic Peptides | 4 | 2023 | 86 | 0.220 |
Why?
| | Porosity | 1 | 2025 | 96 | 0.220 |
Why?
| | Molecular Biology | 1 | 2005 | 59 | 0.220 |
Why?
| | Aconitate Hydratase | 2 | 2002 | 14 | 0.220 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1047 | 0.220 |
Why?
| | Adenosine Monophosphate | 2 | 2003 | 86 | 0.220 |
Why?
| | Diabetes Complications | 1 | 2026 | 222 | 0.210 |
Why?
| | Coculture Techniques | 2 | 2016 | 246 | 0.210 |
Why?
| | Inflammation | 8 | 2023 | 2878 | 0.210 |
Why?
| | Androgens | 1 | 2026 | 186 | 0.210 |
Why?
| | Endocarditis | 2 | 2016 | 39 | 0.210 |
Why?
| | Isocitrates | 2 | 2001 | 2 | 0.210 |
Why?
| | Oxo-Acid-Lyases | 2 | 2001 | 3 | 0.210 |
Why?
| | Receptors, Proteinase-Activated | 1 | 2024 | 2 | 0.210 |
Why?
| | Structure-Activity Relationship | 3 | 2023 | 570 | 0.210 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2024 | 40 | 0.210 |
Why?
| | Escherichia coli | 3 | 2009 | 854 | 0.210 |
Why?
| | Corynebacterium | 1 | 2024 | 49 | 0.210 |
Why?
| | Corynebacterium Infections | 1 | 2024 | 42 | 0.210 |
Why?
| | Biology | 1 | 2005 | 91 | 0.210 |
Why?
| | Trypsin | 1 | 2024 | 76 | 0.210 |
Why?
| | Inflammasomes | 1 | 2025 | 146 | 0.200 |
Why?
| | Receptor, PAR-1 | 1 | 2023 | 16 | 0.200 |
Why?
| | Mice, Knockout | 5 | 2026 | 3121 | 0.200 |
Why?
| | Succinates | 1 | 2023 | 24 | 0.200 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1519 | 0.200 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 103 | 0.200 |
Why?
| | Dermatitis | 1 | 2023 | 18 | 0.200 |
Why?
| | alpha-Defensins | 2 | 2021 | 11 | 0.200 |
Why?
| | Drug Resistance, Bacterial | 2 | 2015 | 196 | 0.200 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2024 | 266 | 0.200 |
Why?
| | Microscopy, Confocal | 3 | 2014 | 321 | 0.200 |
Why?
| | Swine | 4 | 2017 | 833 | 0.200 |
Why?
| | Enzymes | 1 | 2004 | 65 | 0.200 |
Why?
| | Fatty Acids | 2 | 2025 | 450 | 0.200 |
Why?
| | Microscopy, Fluorescence | 3 | 2016 | 416 | 0.190 |
Why?
| | RNA, Bacterial | 4 | 2013 | 189 | 0.190 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 101 | 0.190 |
Why?
| | Streptococcus pneumoniae | 1 | 2024 | 177 | 0.190 |
Why?
| | Respiratory System | 2 | 2016 | 149 | 0.190 |
Why?
| | Enzyme Inhibitors | 5 | 2008 | 824 | 0.190 |
Why?
| | Wound Healing | 1 | 2025 | 351 | 0.190 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2023 | 48 | 0.190 |
Why?
| | Cell Adhesion Molecules | 1 | 2024 | 178 | 0.190 |
Why?
| | Exotoxins | 2 | 2013 | 16 | 0.190 |
Why?
| | Thiazoles | 1 | 2023 | 135 | 0.190 |
Why?
| | Substrate Specificity | 5 | 2026 | 388 | 0.190 |
Why?
| | Lipase | 2 | 2021 | 75 | 0.190 |
Why?
| | Cephalexin | 1 | 2022 | 14 | 0.180 |
Why?
| | Reactive Oxygen Species | 2 | 2024 | 621 | 0.180 |
Why?
| | DNA Transposable Elements | 4 | 2010 | 122 | 0.180 |
Why?
| | Genotype | 4 | 2019 | 1833 | 0.180 |
Why?
| | Lipid Metabolism | 1 | 2025 | 527 | 0.180 |
Why?
| | Testosterone | 1 | 2026 | 419 | 0.180 |
Why?
| | Polysaccharides, Bacterial | 3 | 2017 | 67 | 0.180 |
Why?
| | Bacterial Load | 4 | 2015 | 67 | 0.180 |
Why?
| | Epidermis | 2 | 2020 | 157 | 0.180 |
Why?
| | Basophils | 1 | 2021 | 52 | 0.170 |
Why?
| | Male | 22 | 2026 | 72315 | 0.170 |
Why?
| | Cell Communication | 2 | 2018 | 324 | 0.170 |
Why?
| | Cell Death | 2 | 2021 | 383 | 0.170 |
Why?
| | Propionibacteriaceae | 1 | 2020 | 2 | 0.170 |
Why?
| | Arthritis, Infectious | 1 | 2022 | 72 | 0.170 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2001 | 65 | 0.170 |
Why?
| | Pyruvic Acid | 1 | 2001 | 55 | 0.170 |
Why?
| | Hair Follicle | 1 | 2021 | 48 | 0.170 |
Why?
| | Interleukin-17 | 2 | 2019 | 118 | 0.170 |
Why?
| | Orthopedic Equipment | 1 | 2020 | 5 | 0.170 |
Why?
| | Interleukin-4 | 1 | 2021 | 206 | 0.170 |
Why?
| | Chemotaxis | 1 | 2021 | 122 | 0.170 |
Why?
| | Molecular Structure | 4 | 2020 | 499 | 0.160 |
Why?
| | Polymerase Chain Reaction | 3 | 2016 | 1054 | 0.160 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 2 | 2018 | 23 | 0.160 |
Why?
| | Phage Therapy | 1 | 2020 | 17 | 0.160 |
Why?
| | Photochemotherapy | 1 | 2020 | 39 | 0.160 |
Why?
| | Dysbiosis | 1 | 2022 | 187 | 0.160 |
Why?
| | Shear Strength | 1 | 2020 | 72 | 0.160 |
Why?
| | Fatty Acids, Volatile | 1 | 2020 | 60 | 0.160 |
Why?
| | Photosensitizing Agents | 1 | 2020 | 42 | 0.160 |
Why?
| | Drug Resistance, Microbial | 1 | 2020 | 69 | 0.160 |
Why?
| | Netherton Syndrome | 1 | 2020 | 3 | 0.160 |
Why?
| | Protein Structure, Tertiary | 3 | 2014 | 862 | 0.160 |
Why?
| | Triterpenes | 1 | 2020 | 25 | 0.160 |
Why?
| | Antigens, Bacterial | 1 | 2020 | 125 | 0.160 |
Why?
| | Blotting, Western | 4 | 2016 | 1187 | 0.160 |
Why?
| | Antibodies, Bacterial | 1 | 2020 | 148 | 0.160 |
Why?
| | Gene Deletion | 4 | 2014 | 389 | 0.150 |
Why?
| | Blotting, Southwestern | 1 | 2019 | 2 | 0.150 |
Why?
| | Genomics | 1 | 2005 | 834 | 0.150 |
Why?
| | Coleoptera | 1 | 2019 | 29 | 0.150 |
Why?
| | Lysine | 1 | 2002 | 302 | 0.150 |
Why?
| | Luciferases | 1 | 2019 | 152 | 0.150 |
Why?
| | Phylogeny | 1 | 2024 | 1016 | 0.150 |
Why?
| | Pyrazines | 1 | 2020 | 92 | 0.150 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2013 | 48 | 0.150 |
Why?
| | Bacteria | 3 | 2023 | 889 | 0.150 |
Why?
| | Leishmania major | 1 | 2019 | 8 | 0.150 |
Why?
| | Fruit | 1 | 2020 | 152 | 0.150 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2019 | 14 | 0.150 |
Why?
| | Gene Expression Profiling | 6 | 2019 | 1782 | 0.150 |
Why?
| | Cathelicidins | 4 | 2023 | 41 | 0.150 |
Why?
| | Static Electricity | 1 | 2019 | 113 | 0.150 |
Why?
| | Models, Genetic | 2 | 2016 | 536 | 0.140 |
Why?
| | Skin Diseases | 2 | 2019 | 149 | 0.140 |
Why?
| | Multilocus Sequence Typing | 1 | 2018 | 17 | 0.140 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2019 | 194 | 0.140 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 171 | 0.140 |
Why?
| | Pneumonia, Staphylococcal | 2 | 2018 | 27 | 0.140 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2016 | 199 | 0.140 |
Why?
| | Lung | 5 | 2022 | 4109 | 0.140 |
Why?
| | Environmental Microbiology | 1 | 2018 | 57 | 0.130 |
Why?
| | Bordetella bronchiseptica | 1 | 2017 | 2 | 0.130 |
Why?
| | Bordetella Infections | 1 | 2017 | 4 | 0.130 |
Why?
| | NADPH Oxidases | 2 | 2021 | 124 | 0.130 |
Why?
| | Pseudomonas Infections | 1 | 2019 | 221 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 583 | 0.130 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2019 | 239 | 0.130 |
Why?
| | Transcription, Genetic | 3 | 2008 | 1496 | 0.130 |
Why?
| | Whole Genome Sequencing | 1 | 2018 | 182 | 0.130 |
Why?
| | Conserved Sequence | 2 | 2011 | 245 | 0.130 |
Why?
| | Cell Line | 4 | 2015 | 2882 | 0.120 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2017 | 69 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 616 | 0.120 |
Why?
| | Endocarditis, Bacterial | 2 | 2013 | 44 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 2 | 2017 | 477 | 0.120 |
Why?
| | Ligases | 1 | 2016 | 37 | 0.120 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2016 | 27 | 0.120 |
Why?
| | Vascular Access Devices | 1 | 2016 | 30 | 0.120 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2015 | 7 | 0.120 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2016 | 87 | 0.120 |
Why?
| | Leukocidins | 1 | 2015 | 3 | 0.120 |
Why?
| | Periplasmic Binding Proteins | 1 | 2015 | 13 | 0.110 |
Why?
| | Trachea | 1 | 2017 | 261 | 0.110 |
Why?
| | Emodin | 1 | 2015 | 3 | 0.110 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1999 | 419 | 0.110 |
Why?
| | Multigene Family | 2 | 2013 | 204 | 0.110 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 336 | 0.110 |
Why?
| | Enterotoxins | 2 | 2013 | 89 | 0.110 |
Why?
| | beta-Defensins | 1 | 2014 | 22 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 771 | 0.110 |
Why?
| | Interleukin-8 | 3 | 2024 | 271 | 0.110 |
Why?
| | Toll-Like Receptor 2 | 4 | 2021 | 126 | 0.110 |
Why?
| | Carbon | 2 | 2013 | 203 | 0.110 |
Why?
| | Anthraquinones | 1 | 2014 | 10 | 0.110 |
Why?
| | Penicillium | 1 | 2014 | 8 | 0.110 |
Why?
| | Kinetics | 4 | 2015 | 1627 | 0.110 |
Why?
| | Histocytochemistry | 1 | 2014 | 79 | 0.110 |
Why?
| | Quinazolinones | 1 | 2014 | 19 | 0.110 |
Why?
| | Structural Homology, Protein | 1 | 2014 | 23 | 0.110 |
Why?
| | Phosphoinositide Phospholipase C | 1 | 2014 | 5 | 0.100 |
Why?
| | Plant Leaves | 1 | 2015 | 137 | 0.100 |
Why?
| | Agglutination | 1 | 2013 | 5 | 0.100 |
Why?
| | Organisms, Genetically Modified | 1 | 2013 | 15 | 0.100 |
Why?
| | Methionine Sulfoxide Reductases | 1 | 2013 | 3 | 0.100 |
Why?
| | Virus Cultivation | 1 | 2014 | 31 | 0.100 |
Why?
| | DNA | 3 | 2022 | 1463 | 0.100 |
Why?
| | Mutagenesis, Site-Directed | 3 | 2010 | 381 | 0.100 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 179 | 0.100 |
Why?
| | Nociceptors | 1 | 2013 | 41 | 0.100 |
Why?
| | Cysteine | 2 | 2018 | 210 | 0.100 |
Why?
| | Acyl-Butyrolactones | 1 | 2013 | 10 | 0.100 |
Why?
| | Nitric Oxide | 1 | 2018 | 897 | 0.100 |
Why?
| | Receptors, LDL | 1 | 2013 | 53 | 0.100 |
Why?
| | Apolipoproteins B | 1 | 2013 | 47 | 0.100 |
Why?
| | Blotting, Northern | 1 | 2013 | 204 | 0.100 |
Why?
| | Transcription Initiation Site | 1 | 2013 | 43 | 0.100 |
Why?
| | Transcription Factors | 5 | 2022 | 1741 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2020 | 2496 | 0.090 |
Why?
| | Surface Properties | 2 | 2014 | 410 | 0.090 |
Why?
| | Endopeptidase K | 2 | 2013 | 18 | 0.090 |
Why?
| | Triazoles | 1 | 2014 | 184 | 0.090 |
Why?
| | Receptors, Interleukin-8B | 1 | 2012 | 23 | 0.090 |
Why?
| | Plants, Medicinal | 1 | 2012 | 23 | 0.090 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2013 | 81 | 0.090 |
Why?
| | Protein Transport | 1 | 2014 | 441 | 0.090 |
Why?
| | Culture Media, Conditioned | 3 | 2020 | 111 | 0.090 |
Why?
| | Protein Conformation | 4 | 2026 | 946 | 0.090 |
Why?
| | Mycoplasma fermentans | 1 | 2012 | 1 | 0.090 |
Why?
| | Phenol | 1 | 2012 | 18 | 0.090 |
Why?
| | Mutagenesis, Insertional | 3 | 2009 | 64 | 0.090 |
Why?
| | Vancomycin | 1 | 2013 | 93 | 0.090 |
Why?
| | Enzyme Therapy | 1 | 2011 | 4 | 0.090 |
Why?
| | Alleles | 3 | 2020 | 879 | 0.090 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2011 | 16 | 0.090 |
Why?
| | Erythrocytes | 2 | 2015 | 757 | 0.090 |
Why?
| | Tetracyclines | 1 | 2011 | 17 | 0.090 |
Why?
| | Binding Sites | 3 | 2011 | 1329 | 0.090 |
Why?
| | DNA Mutational Analysis | 1 | 2012 | 406 | 0.090 |
Why?
| | Microarray Analysis | 3 | 2019 | 117 | 0.090 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2011 | 48 | 0.090 |
Why?
| | Ribosomes | 1 | 2013 | 191 | 0.090 |
Why?
| | Incidence | 1 | 2018 | 2879 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2011 | 366 | 0.080 |
Why?
| | Cystic Fibrosis | 2 | 2012 | 1158 | 0.080 |
Why?
| | Protease Inhibitors | 2 | 2010 | 102 | 0.080 |
Why?
| | RNA Polymerase III | 1 | 2010 | 34 | 0.080 |
Why?
| | Autolysis | 1 | 2010 | 3 | 0.080 |
Why?
| | Citrate (si)-Synthase | 2 | 2001 | 57 | 0.080 |
Why?
| | Membrane Glycoproteins | 1 | 2013 | 496 | 0.080 |
Why?
| | Pheromones | 1 | 2010 | 22 | 0.080 |
Why?
| | Complement C3 | 1 | 2011 | 191 | 0.080 |
Why?
| | Ethanol | 1 | 2015 | 627 | 0.080 |
Why?
| | Epistasis, Genetic | 1 | 2010 | 66 | 0.080 |
Why?
| | Chronic Disease | 1 | 2016 | 1813 | 0.080 |
Why?
| | Cytokines | 4 | 2023 | 2061 | 0.080 |
Why?
| | Adenosine Triphosphate | 2 | 2002 | 498 | 0.070 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 780 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 1 | 2012 | 573 | 0.070 |
Why?
| | Biological Products | 1 | 2013 | 252 | 0.070 |
Why?
| | Arthroplasty, Replacement | 1 | 2010 | 47 | 0.070 |
Why?
| | Titanium | 1 | 2010 | 81 | 0.070 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 1 | 2009 | 5 | 0.070 |
Why?
| | Shock, Septic | 1 | 2011 | 216 | 0.070 |
Why?
| | Ligands | 1 | 2011 | 673 | 0.070 |
Why?
| | Phenylmethylsulfonyl Fluoride | 1 | 2008 | 3 | 0.070 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2014 | 341 | 0.070 |
Why?
| | Pain | 1 | 2013 | 779 | 0.070 |
Why?
| | Time Factors | 5 | 2020 | 7173 | 0.070 |
Why?
| | Alcoholism | 1 | 2015 | 817 | 0.070 |
Why?
| | Polymers | 2 | 2022 | 499 | 0.070 |
Why?
| | Gene Knockout Techniques | 3 | 2013 | 116 | 0.070 |
Why?
| | Endopeptidase Clp | 1 | 2007 | 4 | 0.070 |
Why?
| | Prosthesis Design | 1 | 2010 | 357 | 0.070 |
Why?
| | Genetic Complementation Test | 3 | 2014 | 66 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2019 | 442 | 0.060 |
Why?
| | Drug Synergism | 2 | 2020 | 357 | 0.060 |
Why?
| | beta-Lactamases | 1 | 2007 | 51 | 0.060 |
Why?
| | Stimulation, Chemical | 1 | 2006 | 53 | 0.060 |
Why?
| | 4-Butyrolactone | 1 | 2006 | 23 | 0.060 |
Why?
| | Allosteric Regulation | 1 | 2026 | 98 | 0.060 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2006 | 60 | 0.060 |
Why?
| | Respiratory Tract Infections | 1 | 2010 | 397 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 512 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2018 | 8265 | 0.060 |
Why?
| | Biocompatible Materials | 1 | 2010 | 435 | 0.060 |
Why?
| | Burns | 1 | 2010 | 377 | 0.060 |
Why?
| | Catalytic Domain | 1 | 2026 | 232 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2013 | 865 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 2 | 2016 | 91 | 0.060 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2005 | 17 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2006 | 337 | 0.060 |
Why?
| | Sequence Analysis, DNA | 2 | 2014 | 824 | 0.050 |
Why?
| | HIV Protease | 1 | 2004 | 4 | 0.050 |
Why?
| | Flow Cytometry | 1 | 2009 | 1173 | 0.050 |
Why?
| | Genetic Techniques | 1 | 2005 | 67 | 0.050 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2004 | 10 | 0.050 |
Why?
| | Caspase 1 | 1 | 2025 | 148 | 0.050 |
Why?
| | Two-Hybrid System Techniques | 1 | 2004 | 59 | 0.050 |
Why?
| | Ribonucleotide Reductases | 1 | 2004 | 29 | 0.050 |
Why?
| | Tricarboxylic Acids | 1 | 2004 | 11 | 0.050 |
Why?
| | Molecular Dynamics Simulation | 1 | 2026 | 259 | 0.050 |
Why?
| | Phenotype | 3 | 2021 | 3162 | 0.050 |
Why?
| | Bacillus subtilis | 2 | 2020 | 69 | 0.050 |
Why?
| | DNA Restriction Enzymes | 1 | 2004 | 53 | 0.050 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2004 | 23 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2004 | 106 | 0.050 |
Why?
| | Databases, Genetic | 1 | 2005 | 248 | 0.050 |
Why?
| | Catalysis | 2 | 2002 | 322 | 0.050 |
Why?
| | Oligosaccharides | 1 | 2023 | 60 | 0.050 |
Why?
| | Apoptosis | 1 | 2012 | 2430 | 0.050 |
Why?
| | Neutrophil Infiltration | 2 | 2015 | 104 | 0.050 |
Why?
| | Coenzyme A | 1 | 2003 | 7 | 0.050 |
Why?
| | Acetate-CoA Ligase | 1 | 2003 | 2 | 0.050 |
Why?
| | Computational Biology | 2 | 2005 | 680 | 0.050 |
Why?
| | Sirolimus | 1 | 2004 | 281 | 0.050 |
Why?
| | Recombinases | 1 | 2022 | 8 | 0.050 |
Why?
| | Cephalothin | 1 | 2022 | 5 | 0.050 |
Why?
| | Oxacillin | 1 | 2022 | 5 | 0.050 |
Why?
| | Oxidative Stress | 3 | 2014 | 1339 | 0.050 |
Why?
| | Methicillin | 1 | 2022 | 10 | 0.050 |
Why?
| | Cefadroxil | 1 | 2022 | 8 | 0.050 |
Why?
| | Protein Stability | 2 | 2013 | 178 | 0.050 |
Why?
| | Cefazolin | 1 | 2022 | 22 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 851 | 0.050 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2002 | 31 | 0.050 |
Why?
| | Middle Aged | 3 | 2020 | 35875 | 0.050 |
Why?
| | Aged | 2 | 2023 | 25913 | 0.050 |
Why?
| | Green Fluorescent Proteins | 2 | 2016 | 405 | 0.050 |
Why?
| | Sugar Alcohols | 1 | 2002 | 3 | 0.050 |
Why?
| | Leukocytes | 2 | 2015 | 295 | 0.050 |
Why?
| | Cryoprotective Agents | 1 | 2002 | 11 | 0.050 |
Why?
| | U937 Cells | 2 | 2012 | 27 | 0.040 |
Why?
| | Hydrodynamics | 1 | 2022 | 47 | 0.040 |
Why?
| | Viscosity | 1 | 2022 | 90 | 0.040 |
Why?
| | Models, Chemical | 2 | 2002 | 269 | 0.040 |
Why?
| | Tyrosine | 1 | 2022 | 222 | 0.040 |
Why?
| | Propylene Glycol | 2 | 1998 | 9 | 0.040 |
Why?
| | Toll-Like Receptor 1 | 1 | 2021 | 13 | 0.040 |
Why?
| | Proteolysis | 2 | 2012 | 173 | 0.040 |
Why?
| | Lipoylation | 1 | 2021 | 17 | 0.040 |
Why?
| | Photorhabdus | 1 | 2001 | 1 | 0.040 |
Why?
| | Pancreatic Elastase | 1 | 2021 | 55 | 0.040 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2001 | 3 | 0.040 |
Why?
| | Aconitic Acid | 1 | 2001 | 1 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2002 | 224 | 0.040 |
Why?
| | Nematoda | 1 | 2001 | 12 | 0.040 |
Why?
| | Oxaloacetic Acid | 1 | 2001 | 4 | 0.040 |
Why?
| | Glutamate Synthase | 1 | 2001 | 2 | 0.040 |
Why?
| | Ecosystem | 1 | 2006 | 589 | 0.040 |
Why?
| | Codon, Initiator | 1 | 2001 | 11 | 0.040 |
Why?
| | Cell-Free System | 1 | 2001 | 53 | 0.040 |
Why?
| | Brain | 1 | 2013 | 2933 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2001 | 59 | 0.040 |
Why?
| | Adult | 3 | 2020 | 40449 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2004 | 449 | 0.040 |
Why?
| | Pentanoic Acids | 1 | 2020 | 2 | 0.040 |
Why?
| | Isobutyrates | 1 | 2020 | 2 | 0.040 |
Why?
| | Hemiterpenes | 1 | 2020 | 11 | 0.040 |
Why?
| | Sequence Deletion | 2 | 2012 | 193 | 0.040 |
Why?
| | Desmoglein 1 | 1 | 2020 | 2 | 0.040 |
Why?
| | Hemolysis | 2 | 2013 | 243 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 331 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2002 | 630 | 0.040 |
Why?
| | Crystallography, X-Ray | 3 | 2011 | 492 | 0.040 |
Why?
| | Phosphorylation | 1 | 2024 | 1732 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2020 | 122 | 0.040 |
Why?
| | Intermediate Filament Proteins | 1 | 2019 | 57 | 0.040 |
Why?
| | Monocytes | 2 | 2013 | 538 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2001 | 510 | 0.040 |
Why?
| | Solubility | 1 | 2020 | 242 | 0.040 |
Why?
| | Luminescent Measurements | 1 | 2019 | 76 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2020 | 2027 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2023 | 358 | 0.040 |
Why?
| | Cell Division | 1 | 2001 | 766 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 1135 | 0.040 |
Why?
| | Carbon Isotopes | 1 | 1999 | 144 | 0.040 |
Why?
| | HeLa Cells | 1 | 2020 | 650 | 0.040 |
Why?
| | Interferon Type I | 1 | 2019 | 145 | 0.040 |
Why?
| | Multienzyme Complexes | 1 | 1998 | 67 | 0.040 |
Why?
| | Nucleotidyltransferases | 1 | 1998 | 30 | 0.040 |
Why?
| | Triglycerides | 1 | 2021 | 520 | 0.040 |
Why?
| | Animals, Newborn | 2 | 2012 | 902 | 0.040 |
Why?
| | Stress, Mechanical | 1 | 2020 | 494 | 0.030 |
Why?
| | Th17 Cells | 1 | 2019 | 101 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2019 | 455 | 0.030 |
Why?
| | Survival Analysis | 2 | 2012 | 1382 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2018 | 162 | 0.030 |
Why?
| | Toxins, Biological | 1 | 2017 | 12 | 0.030 |
Why?
| | Iron | 1 | 2019 | 359 | 0.030 |
Why?
| | Genes, Regulator | 1 | 1997 | 35 | 0.030 |
Why?
| | Nose | 1 | 2017 | 68 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2020 | 576 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 338 | 0.030 |
Why?
| | Blood Coagulation | 1 | 2018 | 268 | 0.030 |
Why?
| | Immunoglobulin G | 2 | 2011 | 893 | 0.030 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 39 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2019 | 784 | 0.030 |
Why?
| | Ethanolamines | 1 | 1995 | 14 | 0.030 |
Why?
| | Necrosis | 1 | 2017 | 244 | 0.030 |
Why?
| | Propylene Glycols | 1 | 1995 | 27 | 0.030 |
Why?
| | DNA Polymerase I | 1 | 1995 | 31 | 0.030 |
Why?
| | Bronchi | 1 | 2017 | 267 | 0.030 |
Why?
| | Hypersensitivity, Delayed | 1 | 2015 | 29 | 0.030 |
Why?
| | Interleukin-23 | 1 | 2015 | 16 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2015 | 58 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 965 | 0.030 |
Why?
| | Child | 3 | 2022 | 22633 | 0.030 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 100 | 0.030 |
Why?
| | Mice, Hairless | 1 | 2014 | 47 | 0.030 |
Why?
| | Oligonucleotide Probes | 1 | 2014 | 50 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 140 | 0.030 |
Why?
| | Neisseria gonorrhoeae | 1 | 2014 | 29 | 0.030 |
Why?
| | Pyomyositis | 1 | 2014 | 15 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2014 | 148 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 124 | 0.030 |
Why?
| | NAV1.8 Voltage-Gated Sodium Channel | 1 | 2013 | 3 | 0.030 |
Why?
| | Cerebral Ventricles | 1 | 2013 | 54 | 0.030 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 1 | 2013 | 39 | 0.030 |
Why?
| | Lymphatic Diseases | 1 | 2013 | 20 | 0.030 |
Why?
| | Myeloid Cells | 1 | 2015 | 148 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2145 | 0.030 |
Why?
| | Fluorescence | 1 | 2014 | 161 | 0.020 |
Why?
| | Glyoxylates | 1 | 2013 | 8 | 0.020 |
Why?
| | Oxidants | 1 | 2013 | 103 | 0.020 |
Why?
| | Host Specificity | 1 | 2013 | 34 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2015 | 201 | 0.020 |
Why?
| | Fermentation | 1 | 2013 | 32 | 0.020 |
Why?
| | Vancomycin Resistance | 1 | 2013 | 16 | 0.020 |
Why?
| | NADPH Oxidase 2 | 1 | 2013 | 35 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2015 | 348 | 0.020 |
Why?
| | Animals, Outbred Strains | 1 | 2012 | 6 | 0.020 |
Why?
| | Carbohydrates | 1 | 2013 | 66 | 0.020 |
Why?
| | Regulon | 1 | 2013 | 34 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2014 | 151 | 0.020 |
Why?
| | Acetates | 1 | 2013 | 80 | 0.020 |
Why?
| | Daptomycin | 1 | 2012 | 18 | 0.020 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 89 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2013 | 114 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 415 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2014 | 766 | 0.020 |
Why?
| | Hyperalgesia | 1 | 2013 | 131 | 0.020 |
Why?
| | Immunoassay | 1 | 2013 | 109 | 0.020 |
Why?
| | Sus scrofa | 1 | 2012 | 64 | 0.020 |
Why?
| | Peritonitis | 1 | 2013 | 84 | 0.020 |
Why?
| | Bicarbonates | 1 | 2012 | 45 | 0.020 |
Why?
| | Ion Transport | 1 | 2012 | 63 | 0.020 |
Why?
| | High-Throughput Screening Assays | 1 | 2014 | 175 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 113 | 0.020 |
Why?
| | Crystallization | 2 | 2003 | 145 | 0.020 |
Why?
| | Body Fluids | 1 | 2012 | 70 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1966 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2925 | 0.020 |
Why?
| | Cell Membrane Permeability | 1 | 2012 | 85 | 0.020 |
Why?
| | Neutrophil Activation | 1 | 2012 | 85 | 0.020 |
Why?
| | Fluorescent Dyes | 1 | 2014 | 329 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2015 | 502 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 336 | 0.020 |
Why?
| | Glycerophosphates | 1 | 2011 | 4 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2011 | 27 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2013 | 251 | 0.020 |
Why?
| | Complement C3-C5 Convertases | 1 | 2011 | 22 | 0.020 |
Why?
| | Immunoglobulin Fragments | 1 | 2011 | 11 | 0.020 |
Why?
| | Complement C3b | 1 | 2011 | 30 | 0.020 |
Why?
| | Rodent Diseases | 1 | 2011 | 28 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 432 | 0.020 |
Why?
| | Mupirocin | 1 | 2010 | 7 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 143 | 0.020 |
Why?
| | Bacitracin | 1 | 2010 | 5 | 0.020 |
Why?
| | Complement C3a | 1 | 2011 | 40 | 0.020 |
Why?
| | Toll-Like Receptor 9 | 1 | 2011 | 37 | 0.020 |
Why?
| | Neomycin | 1 | 2010 | 7 | 0.020 |
Why?
| | Polymyxin B | 1 | 2010 | 20 | 0.020 |
Why?
| | Ointments | 1 | 2010 | 25 | 0.020 |
Why?
| | Immunoblotting | 1 | 2011 | 300 | 0.020 |
Why?
| | Models, Immunological | 1 | 2011 | 100 | 0.020 |
Why?
| | Bacteriolysis | 1 | 2010 | 10 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 983 | 0.020 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2011 | 223 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 104 | 0.020 |
Why?
| | Gentamicins | 1 | 2010 | 51 | 0.020 |
Why?
| | Meconium | 1 | 2010 | 7 | 0.020 |
Why?
| | Ileus | 1 | 2010 | 13 | 0.020 |
Why?
| | Hot Temperature | 1 | 2013 | 407 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 2010 | 24 | 0.020 |
Why?
| | Up-Regulation | 1 | 2013 | 851 | 0.020 |
Why?
| | Action Potentials | 1 | 2013 | 506 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2013 | 453 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2010 | 397 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2012 | 246 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2012 | 744 | 0.020 |
Why?
| | Pancreatic Diseases | 1 | 2010 | 66 | 0.020 |
Why?
| | Mucus | 1 | 2010 | 73 | 0.020 |
Why?
| | Cell-Derived Microparticles | 1 | 2010 | 75 | 0.020 |
Why?
| | Deoxyribonuclease I | 1 | 2009 | 41 | 0.020 |
Why?
| | Glycoproteins | 1 | 2011 | 355 | 0.020 |
Why?
| | Sheep | 1 | 2012 | 880 | 0.020 |
Why?
| | Radiography, Thoracic | 1 | 2010 | 171 | 0.020 |
Why?
| | Weight Loss | 1 | 2015 | 836 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 2527 | 0.020 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2012 | 370 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2010 | 1306 | 0.020 |
Why?
| | Complement Activation | 1 | 2011 | 411 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2010 | 1047 | 0.020 |
Why?
| | Caulobacter crescentus | 1 | 2007 | 2 | 0.020 |
Why?
| | Oxygen | 1 | 2013 | 995 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 846 | 0.020 |
Why?
| | Pregnancy | 1 | 2019 | 7190 | 0.020 |
Why?
| | Transcriptome | 1 | 2013 | 1045 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2012 | 876 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2011 | 2182 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3409 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2013 | 2832 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2608 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1982 | 0.010 |
Why?
| | Binding, Competitive | 1 | 2003 | 193 | 0.010 |
Why?
| | Acetylation | 1 | 2003 | 252 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3863 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2013 | 2919 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2004 | 675 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 22428 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2001 | 540 | 0.010 |
Why?
| | Reproduction | 1 | 2001 | 207 | 0.010 |
Why?
| | Pentosyltransferases | 1 | 1998 | 6 | 0.010 |
Why?
| | Ethanolamine | 1 | 1995 | 6 | 0.010 |
Why?
| | Sequence Analysis | 1 | 1995 | 35 | 0.010 |
Why?
| | Rats | 1 | 1995 | 5597 | 0.000 |
Why?
|
|
Horswill's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|